Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
1853265
Title:
INHIBITEURS DE FARNESYL TRANSFERASE DESTINES A TRAITER LES LAMINOPATHIES, LE VIEILLISSEMENT CELLULAIRE ET L'ATHEROSCLEROSE
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
067339846
WO application number:
US2006002977
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
1853265
WO publication number:
WO2006081444
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
27/01/2006
Grant date:
27/01/2016
EP publication date:
14/11/2007
WO publication date:
03/08/2006
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
27/01/2016
EP B1 publication date:
27/01/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
27/01/2026
Applicant
1
Name:
The Government of the United States of America as
represented by the Secretary of the Department of
Health and Human Services
Legal Form:
From:
27/01/2016
Address:
National Institutes of Health,
Suite 325,
6011 Executive Boulevard, Rockville, MD 20852-3804, United States (US)
To:
2
Name:
The Progeria Research Foundation, Inc.
Legal Form:
From:
27/01/2016
Address:
P.O. Box 3453, Peabody, MA 01961-3453, United States (US)
To:
3
Name:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Legal Form:
From:
27/01/2016
Address:
Wolverine Tower
Room 2071,
3003 South State Street, Ann Arbor,
Michigan 48109-1290, United States (US)
To:
4
Name:
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Legal Form:
From:
27/01/2016
Address:
Office of Technology Development,
Campus Box 4105,
308 Bynum Hall, Chapel Hill, NC 27599-4105, United States (US)